Literature DB >> 16169931

Chromosomal copy number changes in patients with non-syndromic X linked mental retardation detected by array CGH.

D Lugtenberg1, A P M de Brouwer, T Kleefstra, A R Oudakker, S G M Frints, C T R M Schrander-Stumpel, J P Fryns, L R Jensen, J Chelly, C Moraine, G Turner, J A Veltman, B C J Hamel, B B A de Vries, H van Bokhoven, H G Yntema.   

Abstract

Several studies have shown that array based comparative genomic hybridisation (CGH) is a powerful tool for the detection of copy number changes in the genome of individuals with a congenital disorder. In this study, 40 patients with non-specific X linked mental retardation were analysed with full coverage, X chromosomal, bacterial artificial chromosome arrays. Copy number changes were validated by multiplex ligation dependent probe amplification as a fast method to detect duplications and deletions in patient and control DNA. This approach has the capacity to detect copy number changes as small as 100 kb. We identified three causative duplications: one family with a 7 Mb duplication in Xp22.2 and two families with a 500 kb duplication in Xq28 encompassing the MECP2 gene. In addition, we detected four regions with copy number changes that were frequently identified in our group of patients and therefore most likely represent genomic polymorphisms. These results confirm the power of array CGH as a diagnostic tool, but also emphasise the necessity to perform proper validation experiments by an independent technique.

Entities:  

Mesh:

Year:  2005        PMID: 16169931      PMCID: PMC2563232          DOI: 10.1136/jmg.2005.036178

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  34 in total

1.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

2.  Segmental duplications: organization and impact within the current human genome project assembly.

Authors:  J A Bailey; A M Yavor; H F Massa; B J Trask; E E Eichler
Journal:  Genome Res       Date:  2001-06       Impact factor: 9.043

3.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

4.  Another family with nonspecific X-linked mental retardation (MRX78) maps to Xp11.4-p11.23.

Authors:  Bert B A de Vries; Guido J Breedveld; Wouter H Deelen; Martijn H Breuning; Martinus F Niermeijer; Peter Heutink
Journal:  Am J Med Genet       Date:  2002-09-01

5.  High resolution profiling of X chromosomal aberrations by array comparative genomic hybridisation.

Authors:  J A Veltman; H G Yntema; D Lugtenberg; H Arts; S Briault; E H L P G Huys; K Osoegawa; P de Jong; H G Brunner; A Geurts van Kessel; H van Bokhoven; E F P M Schoenmakers
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

6.  Mapping and characterization of the mouse and human SS18 genes, two human SS18-like genes and a mouse Ss18 pseudogene.

Authors:  D R de Bruijn; E Kater-Baats; M Eleveld; G Merkx; A Geurts Van Kessel
Journal:  Cytogenet Cell Genet       Date:  2001

7.  Systematic analysis of X-inactivation in 19XLMR families: extremely skewed profiles in carriers in three families.

Authors:  M Raynaud; M P Moizard; B Dessay; S Briault; A Toutain; C Gendrot; N Ronce; C Moraine
Journal:  Eur J Hum Genet       Date:  2000-04       Impact factor: 4.246

8.  High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization.

Authors:  Joris A Veltman; Eric F P M Schoenmakers; Bert H Eussen; Irene Janssen; Gerard Merkx; Brigitte van Cleef; Conny M van Ravenswaaij; Han G Brunner; Dominique Smeets; Ad Geurts van Kessel
Journal:  Am J Hum Genet       Date:  2002-04-09       Impact factor: 11.025

9.  Functional analysis of ARHGAP6, a novel GTPase-activating protein for RhoA.

Authors:  S K Prakash; R Paylor; S Jenna; N Lamarche-Vane; D L Armstrong; B Xu; M A Mancini; H Y Zoghbi
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

10.  Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features.

Authors:  C Shaw-Smith; R Redon; L Rickman; M Rio; L Willatt; H Fiegler; H Firth; D Sanlaville; R Winter; L Colleaux; M Bobrow; N P Carter
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

View more
  31 in total

1.  Molecular and clinical characterization of a small duplication Xp in a human female with psychiatric disorders.

Authors:  Maria Piccione; Cinzia Sanfilippo; Simona Cavani; Patrizia Salatiello; Michela Malacarne; Mauro Pierluigi; Marco Fichera; Daniela Luciano; Giovanni Corsello
Journal:  J Genet       Date:  2011-12       Impact factor: 1.166

2.  Pure de-novo 5 Mb duplication at Xp11.22-p11.23 in a male: phenotypic and molecular characterization.

Authors:  C Bonnet; M J Grégoire; K Brochet; E Raffo; B Leheup; P Jonveaux
Journal:  J Hum Genet       Date:  2006-08-10       Impact factor: 3.172

3.  X-linked congenital ptosis and associated intellectual disability, short stature, microcephaly, cleft palate, digital and genital abnormalities define novel Xq25q26 duplication syndrome.

Authors:  R S Møller; L R Jensen; S M Maas; J Filmus; M Capurro; C Hansen; C L M Marcelis; K Ravn; J Andrieux; M Mathieu; M Kirchhoff; O K Rødningen; N de Leeuw; H G Yntema; G Froyen; J Vandewalle; K Ballon; E Klopocki; S Joss; J Tolmie; A C Knegt; A M Lund; H Hjalgrim; A W Kuss; N Tommerup; R Ullmann; A P M de Brouwer; P Strømme; S Kjaergaard; Z Tümer; T Kleefstra
Journal:  Hum Genet       Date:  2013-12-11       Impact factor: 4.132

Review 4.  Gene therapy for neurological disorders: progress and prospects.

Authors:  Benjamin E Deverman; Bernard M Ravina; Krystof S Bankiewicz; Steven M Paul; Dinah W Y Sah
Journal:  Nat Rev Drug Discov       Date:  2018-08-10       Impact factor: 84.694

5.  Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation.

Authors:  Zhaolan Zhou; Elizabeth J Hong; Sonia Cohen; Wen-Ning Zhao; Hsin-Yi Henry Ho; Lauren Schmidt; Wen G Chen; Yingxi Lin; Erin Savner; Eric C Griffith; Linda Hu; Judith A J Steen; Charles J Weitz; Michael E Greenberg
Journal:  Neuron       Date:  2006-10-19       Impact factor: 17.173

Review 6.  The MECP2 duplication syndrome.

Authors:  Melissa B Ramocki; Y Jane Tavyev; Sarika U Peters
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

7.  Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy.

Authors:  Dorien Lugtenberg; Tjitske Kleefstra; Astrid R Oudakker; Willy M Nillesen; Helger G Yntema; Andreas Tzschach; Martine Raynaud; Dietz Rating; Hubert Journel; Jamel Chelly; Cyril Goizet; Didier Lacombe; Jean-Michel Pedespan; Bernard Echenne; Gholamali Tariverdian; Declan O'Rourke; Mary D King; Andrew Green; Margriet van Kogelenberg; Hilde Van Esch; Jozef Gecz; Ben C J Hamel; Hans van Bokhoven; Arjan P M de Brouwer
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

8.  Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation.

Authors:  Raman P Nagarajan; Amber R Hogart; Ynnez Gwye; Michelle R Martin; Janine M LaSalle
Journal:  Epigenetics       Date:  2006 Oct-Dec       Impact factor: 4.528

9.  Genetic copy number variants in sib pairs both affected with schizophrenia.

Authors:  Chia-Huei Lee; Chih-Min Liu; Chun-Chiang Wen; Shun-Min Chang; Hai-Gwo Hwu
Journal:  J Biomed Sci       Date:  2010-01-11       Impact factor: 8.410

10.  Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus.

Authors:  Shay Ben-Shachar; Maria Chahrour; Christina Thaller; Chad A Shaw; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.